U.S. STOCKS ON THE MOVE-GlycoMimetics, Diamond Offshore, Eyegate Pharmaceuticals

iPic Entertainment

05/08/2019 12:47

* Eikon search string for individual stock moves:  STXBZ 
    * The Day Ahead newsletter: http://tmsnrt.rs/2ggOmBi
    * The Morning News Call newsletter: http://tmsnrt.rs/2fwPLTh

U.S. stock index futures pointed to more losses on Monday as China's yuan hit
its lowest in a decade, spurring a continuation of a sell-off on trade concerns
on Friday that generated the S&P 500's worst weekly performance of 2019.  .N 
    At 7:19 ET, Dow e-minis  1YMc1  were down 1.39% at 26,081. S&P 500 e-minis
 ESc1  were down 1.48% at 2,889, while Nasdaq 100 e-minis  NQc1  were down 1.87%
at 7,558.25.
 
 The top three NYSE percentage gainers premarket  .PRPG.NQ :
 ** Norwegian Cruise Line Holdings Ltd  NCLH.N , up 9.8% 
 ** Pioneer Energy Services Corp  PES.N , up 9.2%
 ** Winnebago Industries Inc  WGO.N , up 6.3%
 
 The top three NYSE percentage losers premarket  .PRPL.NQ :
 ** Diamond Offshore Drilling Inc  DO.N , down 8.4%
 ** CNX Resources Corp  CNX.N , down 5.4%
 ** Cellcom Israel Ltd  CEL.N , down 5.3%
 
 The top three Nasdaq percentage gainers premarket  .PRPG.O :
 ** Adial Pharmaceuticals Inc  ADIL.O , up 22.6%
 ** Eyegate Pharmaceuticals Inc  EYEG.O , up 12.9%
 ** NII Holdings Inc  NIHD.O , up 10.11% 
 
 The top three Nasdaq percentage losers premarket  .PRPL.O :
 ** Glycomimetics Inc  GLYC.O , down 47.3%
 ** Ipic Entertainment Inc  IPIC.O , down 40.1%
 ** Scworx Corp  WORX.O , down 8.8%
 
 
 ** Chevron Corp  CVX.N : down 1.2% premarket
 BUZZ-Street View: Permian remains key to Chevron's future growth urn:newsml:reuters.com:*:nL4N2512AQ
   
 ** Exxon Mobil Corp  XOM.N : down 1.0% premarket
 BUZZ-Street View: Challenging Q2 for Exxon, with mounting macro
headwinds urn:newsml:reuters.com:*:nL4N2512N0
 
 ** Mercer International MERC.O : down 2.2% premarket
 BUZZ-Down on RBC rating downgrade urn:newsml:reuters.com:*:nL4N2512RV
 
 ** TTM Technologies, Inc  TTMI.O : down 1.8% premarket
 BUZZ-JPM cuts to 'neutral' on near-term risks urn:newsml:reuters.com:*:nL4N2512UI
 
 ** GlycoMimetics Inc  GLYC.O : down 50.2% premarket
 BUZZ-Halves after blood disorder drug fails late-stage trial urn:newsml:reuters.com:*:nL4N2512VM
    
 

 (Compiled by Arunima Kumar in Bengaluru)
 ((RM:arunima.kumar.thomsonreuters.com@reuters.net))